Merck's Ken Frazier On Risk, Capital Allocation, Top-Line Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck's new CEO Ken Frazier and its chairman and former CEO Richard Clark, appeared jointly at a Goldman Sachs conference on Jan. 6, commenting on optimizing capital allocation, portfolio momentum, and dealing with risk and innovation in the changing world market.